Form 8-K - Current report:
SEC Accession No. 0001683168-20-004263
Filing Date
2020-12-11
Accepted
2020-12-11 08:09:54
Documents
28
Period of Report
2020-12-11
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cns_8k.htm 8-K 22448
2 INVESTOR PRESENTATION cns_ex9901.htm EX-99.1 45015
3 GRAPHIC image_001.jpg GRAPHIC 175212
4 GRAPHIC image_002.jpg GRAPHIC 134536
5 GRAPHIC image_003.jpg GRAPHIC 173548
6 GRAPHIC image_004.jpg GRAPHIC 252491
7 GRAPHIC image_005.jpg GRAPHIC 133256
8 GRAPHIC image_006.jpg GRAPHIC 245411
9 GRAPHIC image_007.jpg GRAPHIC 234496
10 GRAPHIC image_008.jpg GRAPHIC 168176
11 GRAPHIC image_009.jpg GRAPHIC 259450
12 GRAPHIC image_010.jpg GRAPHIC 188120
13 GRAPHIC image_011.jpg GRAPHIC 178378
14 GRAPHIC image_012.jpg GRAPHIC 221799
15 GRAPHIC image_013.jpg GRAPHIC 234525
16 GRAPHIC image_014.jpg GRAPHIC 252088
17 GRAPHIC image_015.jpg GRAPHIC 205044
18 GRAPHIC image_016.jpg GRAPHIC 259561
19 GRAPHIC image_017.jpg GRAPHIC 200171
20 GRAPHIC image_018.jpg GRAPHIC 267139
21 GRAPHIC image_019.jpg GRAPHIC 175071
22 GRAPHIC image_020.jpg GRAPHIC 271503
23 GRAPHIC image_021.jpg GRAPHIC 147874
24 GRAPHIC image_022.jpg GRAPHIC 161801
25 GRAPHIC image_023.jpg GRAPHIC 236204
26 GRAPHIC image_024.jpg GRAPHIC 180094
27 GRAPHIC image_025.jpg GRAPHIC 177764
28 GRAPHIC image_026.jpg GRAPHIC 175212
  Complete submission text file 0001683168-20-004263.txt   7384072
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185 X701
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

EIN.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39126 | Film No.: 201382277
SIC: 2834 Pharmaceutical Preparations